Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]

Saved in:
Bibliographic Details
Published inPharmacology & therapeutics (Oxford) Vol. 243; p. 108336
Main Authors Liu, Xinlin, Deng, Junwen, Yuan, Yang, Chen, Wujun, Sun, Wenshe, Wang, Yanhong, Huang, Haiming, Liang, Bing, Ming, Tao, Wen, Jialian, Huang, Binghuan, Xing, Dongming
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.03.2023
Online AccessGet full text

Cover

ArticleNumber 108336
Author Sun, Wenshe
Ming, Tao
Huang, Binghuan
Huang, Haiming
Liu, Xinlin
Deng, Junwen
Chen, Wujun
Liang, Bing
Wen, Jialian
Yuan, Yang
Wang, Yanhong
Xing, Dongming
Author_xml – sequence: 1
  givenname: Xinlin
  surname: Liu
  fullname: Liu, Xinlin
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 2
  givenname: Junwen
  surname: Deng
  fullname: Deng, Junwen
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 3
  givenname: Yang
  surname: Yuan
  fullname: Yuan, Yang
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 4
  givenname: Wujun
  surname: Chen
  fullname: Chen, Wujun
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 5
  givenname: Wenshe
  surname: Sun
  fullname: Sun, Wenshe
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 6
  givenname: Yanhong
  surname: Wang
  fullname: Wang, Yanhong
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 7
  givenname: Haiming
  surname: Huang
  fullname: Huang, Haiming
  organization: Shanghai Asia United Antibody Medical Co., Ltd, Shanghai 201203, China
– sequence: 8
  givenname: Bing
  surname: Liang
  fullname: Liang, Bing
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 9
  givenname: Tao
  surname: Ming
  fullname: Ming, Tao
  organization: Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100094, China
– sequence: 10
  givenname: Jialian
  surname: Wen
  fullname: Wen, Jialian
  organization: School of Social Science, The University of Manchester, Manchester, UK
– sequence: 11
  givenname: Binghuan
  surname: Huang
  fullname: Huang, Binghuan
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
– sequence: 12
  givenname: Dongming
  surname: Xing
  fullname: Xing, Dongming
  email: xdm_tsinghua@163.com
  organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36804040$$D View this record in MEDLINE/PubMed
BookMark eNqFUctuEzEUtVARTQu_gLxCZTHBr8yDXYl4SRWwCBISQpYfd1JHM-PB9kTKrh9Sfq5fgqcpsEReXOnqPO7xOUMngx8AIUzJkhJavtotx2sV-nQNQS0ZYSyva87LR2hB66opMubbCVrkwYuKrepTdBbjjhAiBGFP0CkvayLyW6DbtQ_BbWGwU4-Tx3c3t5d2rwYDEbsBb4IfWZFU2EICi-8Nx8Nr_MnvocMq81LEarDYj6MPaRpccpmp4eDzUgdQMWEzy4W7m1_4-5f5bGV857cH_AJv7vVgSs5EzHiDL-YwL3POmjXlj6focau6CM8e5jn6-u7tZv2huPr8_uP68qowjIqyUIKR1oCqdMlLSistaENrIFZQ1jartmk1b6qWCKstrBRjWjOhGqAGBAGz4ufo4qg7Bv9zgphk76KBrlMD-ClKVlV1U3FSVxlaH6Em-BgDtHIMrlfhICmRczdyJ_91I-c48thNpj5_cJl0D_Yv8U8ZGfDmCICcde8gyGgc5L-zLoBJ0nr3f5ffMsepAA
ContentType Journal Article
Copyright 2022 The Author(s)
Copyright_xml – notice: 2022 The Author(s)
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.pharmthera.2022.108336
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1879-016X
EndPage 108336
ExternalDocumentID 10_1016_j_pharmthera_2022_108336
36804040
S0163725822002303
Genre Published Erratum
Correction/Retraction
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
123
1B1
1RT
1~.
1~5
29O
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABFNM
ABMAC
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
WUQ
Y6R
ZGI
ZXP
~G-
AAXKI
AFJKZ
AKRWK
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c2146-a420fcea7b636117b41918e0d412f95f9fb397f04dbde5a22bb24a9e1ce40ec53
IEDL.DBID AIKHN
ISSN 0163-7258
IngestDate Sat Oct 05 05:10:29 EDT 2024
Thu Sep 26 18:20:53 EDT 2024
Sat Sep 28 08:19:01 EDT 2024
Fri Feb 23 02:37:48 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2146-a420fcea7b636117b41918e0d412f95f9fb397f04dbde5a22bb24a9e1ce40ec53
Notes erratum
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
OpenAccessLink https://doi.org/10.1016/j.pharmthera.2022.108336
PMID 36804040
PQID 2778973087
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_2778973087
crossref_primary_10_1016_j_pharmthera_2022_108336
pubmed_primary_36804040
elsevier_sciencedirect_doi_10_1016_j_pharmthera_2022_108336
PublicationCentury 2000
PublicationDate March 2023
2023-Mar
2023-03-00
20230301
PublicationDateYYYYMMDD 2023-03-01
PublicationDate_xml – month: 03
  year: 2023
  text: March 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pharmacology & therapeutics (Oxford)
PublicationTitleAlternate Pharmacol Ther
PublicationYear 2023
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References 36208791 - Pharmacol Ther. 2022 Nov;239:108296
References_xml
SSID ssj0004402
Score 2.4563346
SecondaryResourceType publication_corrigendum
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 108336
Title Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]
URI https://dx.doi.org/10.1016/j.pharmthera.2022.108336
https://www.ncbi.nlm.nih.gov/pubmed/36804040
https://search.proquest.com/docview/2778973087
Volume 243
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1di9QwFA27sy--iN-OrssVZFHYOk2aNK0-DYPLqDgsOAsLIiFfhRFtS2dmYV5kf8j65_aXmDSts4KC4Gtpmkvu7b0n7Tk3CD3DEmeK-S_3KjURxUpHkhMTGZY4LJdQbaVXI3-YpdNT-u6Mne2gSa-F8bTKLveHnN5m6-7KqFvNUb1YjD46sJJwwlyFa4F0sov2XDmidID2xm_fT2dbeSRtqYf-_sgP6Ag9geZV-w7RrdbJbRYJ8Zy7pO3X_Mcq9TcU2laj41voZgcjYRwsvY12bHkHHZ6EPtSbI5hvZVXLIziEk22H6s1ddDmpmsa34TTrb7Cq4Orichy4AEtYlDBvqppEgSNuDQSJ1uYVzKpz-xWkF2MtQZYGqtqj93XZdmUF1YphQHma-wq0f1xzdfEDPl2f3Nly3TYgSQ7P_ZK8cKuVkTz9fA-dHr-ZT6ZRd0xDpP2p4JGkJC6cT7lKkxRjrqjbA2Y2NhSTImdFXigHeoqYGmUsk4QoRajMLdaWxlaz5D4alFVpHyIwWmVuv2m15BnVaSqLrIiZtdRFEmcaDxHu3SLq0I1D9DS1L2LrSuHtFsGVQ_S695_4LbKEKxr_MPpp73LhXjz_N0WWtlovBeE8y7lvqDhED0Is_LIpSTOXHGn86L_mfoxu-MPtA-NtHw1Wzdo-cRBopQ7Q7svv-KAL9J_PXQj_
link.rule.ids 315,786,790,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1da9RAFB1qfdAX8dttq15BikLjJpNJJtGnslhWbZeCWyiIDPMVWNEkZHeFfSn9IfXP9Zc4N5O4FRQEX8Mkc5l7c--Z5NwzhDyPZJSpBL_cq9QELFI6kJyawCSxw3Ix01ZiN_LRJB2fsPenyekGGfW9MEir7HK_z-lttu6uDLvVHNaz2fCjAysxp4mrcC2Qjq-R64gGkNf16mzN82CsJR7i6ACHd3QeT_KqUR-67XRyW0VKkXEXt2rNf6xRf8OgbS06uE1udSAS9r2dd8iGLe-S3WOvQr3ag-m6qWq-B7twvNanXt0jF6OqaVCE0yy_waKCy_OLfc8EmMOshGlT1TTwDHFrwDdorV7DpPpuv4LEVqw5yNJAVSN2X5atJiuothUGFJLcF6Dxcc3l-Q_4dHVyZ8tV24DGObzAJXnpViujefr5Pjk5eDsdjYPukIZA45nggWQ0LJxHuUrjNIq4Ym4HmNnQsIgWeVLkhXKQpwiZUcYmklKlKJO5jbRlodVJ_IBsllVpHxEwWmVut2m15BnTaSqLrAgTa5mLI57oaECi3i2i9locoiepfRFrVwq0W3hXDsib3n_it7gSrmT8w93PepcL99rhvxRZ2mo5F5TzLOcopzggD30s_LIpTjOXGlm49V9zPyU3xtOjQ3H4bvJhm9zEY-49922HbC6apX3swNBCPWmD_SczMwnU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corrigendum+to+%E2%80%9CAdvances+in+Trop2-targeted+therapy%3A+Novel+agents+and+opportunities+beyond+breast+cancer%E2%80%9D+%5BPharmacology+%26+Therapeutics+239+%282022%29+108296%5D&rft.jtitle=Pharmacology+%26+therapeutics+%28Oxford%29&rft.au=Liu%2C+Xinlin&rft.au=Deng%2C+Junwen&rft.au=Yuan%2C+Yang&rft.au=Chen%2C+Wujun&rft.date=2023-03-01&rft.pub=Elsevier+Inc&rft.issn=0163-7258&rft.eissn=1879-016X&rft.volume=243&rft_id=info:doi/10.1016%2Fj.pharmthera.2022.108336&rft.externalDocID=S0163725822002303
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-7258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-7258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-7258&client=summon